LeMaitre Vascular, Inc. provides devices, implants, and services for the treatment of peripheral vascular disease. The company develops, manufactures, and markets disposable and implantable vascular devices for vascular surgeons, with products used in arteries and veins.
Recurring LMAT news includes quarterly financial results, guidance, dividend declarations, and management presentations at healthcare investor conferences. Company updates also discuss product categories such as Artegraft, grafts, valvulotomes, and carotid shunts, along with sales activity across the Americas, EMEA, and Asia Pacific.
LeMaitre Vascular, listed on Nasdaq under the symbol LMAT, will be presented by President David Roberts at the UBS Virtual Global Healthcare Conference on May 20, 2020, at 8:20 AM EDT. The company specializes in developing and marketing devices for peripheral vascular disease, impacting over 200 million people globally. Their extensive product range focuses on disposable and implantable vascular devices tailored for vascular surgeons, enhancing treatment options for patients.